{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:06:03Z","timestamp":1792735563337,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T00:00:00Z","timestamp":1592870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T00:00:00Z","timestamp":1592870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>There are currently two widely used methods for preoperative localization of ductal carcinoma in situ (DCIS) of the breast: wire-guided localization (WGL) and radioactive seed localization (RSL). Several studies compared these localization techniques in small cohorts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The aim of this study was to compare the surgical resection margin status between RSL and WGL in a large national cohort of patients with DCIS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods<\/jats:title>\n                    <jats:p>\n                      We included patients from the Dutch Pathology Registry who underwent breast-conserving surgery for DCIS by either RSL (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091851) or WGL (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20092187) between 2009 and 2019. Several clinicopathological characteristics were compared between these two groups, including resection margin status and number of re-excisions.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Patients undergoing RSL were younger (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.014) and were more often diagnosed with a large DCIS (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.013), high grade DCIS (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and comedonecrosis (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) compared with patients undergoing WGL. There was no significant difference in resection margin status between both groups (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.089) and the number of re-excisions (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.429). However, in case of re-excision, patients in the RSL group were more often treated with breast-conserving surgery (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.029).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this large national cohort study of patients with DCIS, we demonstrated that there was no difference in resection margin status between both procedures, or in the number of re-excisions, but patients in the RSL group were more often treated with breast-conserving therapy in case of a re-excision.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1245\/s10434-020-08744-8","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T12:20:15Z","timestamp":1592914815000},"page":"5296-5302","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Radioactive Seed Versus Wire-Guided Localization for Ductal Carcinoma in Situ of the Breast: Comparable Resection Margins"],"prefix":"10.1245","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3199-3661","authenticated-orcid":false,"given":"Marie Colombe","family":"Agahozo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofie A.M.","family":"Berghuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"van den Broek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linetta B.","family":"Koppert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge-Marie","family":"Obdeijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolien H. M.","family":"van Deurzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,23]]},"reference":[{"issue":"21","key":"8744_CR1","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1056\/NEJMoa1206809","volume":"367","author":"A Bleyer","year":"2012","unstructured":"Bleyer A, Welch G. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med. 2012;367(21):1998\u20132005. 10.1056\/NEJMoa1206809.","journal-title":"N Engl J Med."},{"key":"8744_CR2","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1136\/bmj.e797","volume":"344","author":"NLP Barnes","year":"2012","unstructured":"Barnes NLP, Ooi JL, Yarnold JR, Bundred NJ. Ductal carcinoma in situ of the breast. How does DCIS develop? BMJ. 2012;344:e797. 10.1136\/bmj.e797.","journal-title":"BMJ."},{"issue":"4","key":"8744_CR3","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41416-019-0478-6","volume":"121","author":"M van Seijen","year":"2019","unstructured":"van Seijen M, Lips EH, Thompson AM, et al. Ductal carcinoma in situ: to treat or not to treat, that is the question. Br J Cancer. 2019;121(4):285\u2013292. 10.1038\/s41416-019-0478-6.","journal-title":"Br J Cancer"},{"key":"8744_CR4","unstructured":"Collins LC, Laronga C, FACS, Wong JA. Ductal carcinoma in situ: treatment and prognosis\u2014UpToDate. 2017. Available at: https:\/\/www.uptodate.com\/contents\/ductal-carcinoma-in-situ-treatment-and-prognosis?source\u2009=\u2009see_link. Accessed 27 Feb 2017."},{"issue":"1","key":"8744_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11864-012-0217-1","volume":"14","author":"N Bijker","year":"2013","unstructured":"Bijker N, Donker M, Wesseling J, Den Heeten GJ, Rutgers EJT. Is DCIS breast cancer, and how do i treat it? Curr Treat Options Oncol. 2013;14(1):75\u201387. 10.1007\/s11864-012-0217-1.","journal-title":"Curr Treat Options Oncol."},{"issue":"5","key":"8744_CR6","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/his.13116","volume":"70","author":"MS Toss","year":"2017","unstructured":"Toss MS, Pinder SE, Green AR, et al. Breast conservation in ductal carcinoma in situ (DCIS): what defines optimal margins? Histopathology. 2017;70(5):681\u2013692. 10.1111\/his.13116.","journal-title":"Histopathology"},{"issue":"7","key":"8744_CR7","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1002\/cncr.31221","volume":"124","author":"M Pilewskie","year":"2018","unstructured":"Pilewskie M, Morrow M. Margins in breast cancer: How much is enough? Cancer. 2018;124(7):1335\u20131341. 10.1002\/cncr.31221.","journal-title":"Cancer."},{"issue":"Suppl 5","key":"8744_CR8","doi-asserted-by":"publisher","first-page":"v8","DOI":"10.1093\/annonc\/mdv298","volume":"26","author":"E Senkus","year":"2015","unstructured":"Senkus E, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rutgers E. Primary breast cancer: ESMO Clinical Practice clinical practice guidelines. Ann Oncol. 2015;26 Suppl\u00a05:v8\u201330. 10.1093\/annonc\/mdv298.","journal-title":"Ann Oncol."},{"issue":"12","key":"8744_CR9","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1245\/s10434-016-5449-z","volume":"23","author":"M Morrow","year":"2016","unstructured":"Morrow M, Van Zee KJ, Solin LJ, et al. Society of Surgical Oncology\u2013American Society for Radiation Oncology\u2013American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Ductal Carcinoma In Situ. Ann Surg Oncol. 2016;23(12):3801\u20133810. 10.1245\/s10434-016-5449-z.","journal-title":"Ann Surg Oncol."},{"issue":"10","key":"8744_CR10","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1016\/j.ejso.2017.06.007","volume":"43","author":"EL Vos","year":"2017","unstructured":"Vos EL, Gaal J, Verhoef C, Brouwer K, van Deurzen CHM, Koppert LB. Focally positive margins in breast conserving surgery: Predictors, residual disease, and local recurrence. Eur J Surg Oncol. 2017;43(10):1846\u20131854. 10.1016\/j.ejso.2017.06.007.","journal-title":"Eur J Surg Oncol."},{"key":"8744_CR11","unstructured":"NABON. Breast Cancer Dutch Guideline 2012, Version 2.0.; 2012. Available at: https:\/\/oncoline.nl\/uploaded\/docs\/mammacarcinoom\/Dutch Breast Cancer Guideline 2012.pdf. Accessed 12 Sep 2018."},{"issue":"3","key":"8744_CR12","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ejca.2014.12.003","volume":"51","author":"EL Vos","year":"2015","unstructured":"Vos EL, Jager A, Verhoef C, Voogd AC, Koppert LB. Overall survival in patients with a re-excision following breast conserving surgery compared to those without in a large population-based cohort. Eur J Cancer. 2015;51(3):282\u2013291. 10.1016\/j.ejca.2014.12.003.","journal-title":"Eur J Cancer."},{"key":"8744_CR13","unstructured":"NABON. Borstkanker: Landelijke Richtlijn, Versie 1.0. 2018."},{"issue":"1081","key":"8744_CR14","doi-asserted-by":"publisher","first-page":"20170268","DOI":"10.1259\/bjr.20170268","volume":"91","author":"R Milligan","year":"2018","unstructured":"Milligan R, Pieri A, Critchley A, et al. Radioactive seed localization compared with wireguided localization of non-palpable breast carcinoma in breast conservation surgery: the first experience in the United Kingdom. Br J Radiol. 2018;91(1081):20170268. 10.1259\/bjr.20170268.","journal-title":"Br J Radiol."},{"issue":"5","key":"8744_CR15","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1148\/rg.2015140293","volume":"35","author":"SH Goudreau","year":"2015","unstructured":"Goudreau SH, Joseph JP, Seiler SJ. Preoperative radioactive seed localization for nonpalpable breast lesions: Technique, pitfalls, and solutions. Radiographics. 2015;35(5):1319\u20131334. 10.1148\/rg.2015140293.","journal-title":"Radiographics"},{"issue":"1","key":"8744_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/SLA.0000000000002101","volume":"266","author":"L Langhans","year":"2017","unstructured":"Langhans L, Tvedskov TF, Klausen TL, et al. Radioactive Seed Localization or Wire-guided Localization of Nonpalpable Invasive and in Situ Breast Cancer: A Randomized, Multicenter, Open-label Trial. Ann Surg. 2017;266(1):29\u201335. 10.1097\/SLA.0000000000002101.","journal-title":"Open-label Trial. Ann Surg."},{"issue":"4","key":"8744_CR17","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/tbj.13023","volume":"24","author":"J Xu","year":"2018","unstructured":"Xu XJ, Li JJ, Ji WB. An updated meta-analysis of radioactive seed localization versus wire-guided localization in the treatment of nonpalpable breast lesions. Breast J. 2018;24(4):673\u2013675. 10.1111\/tbj.13023.","journal-title":"Breast J."},{"issue":"13","key":"8744_CR18","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1002\/bjs.9946","volume":"102","author":"JD Luiten","year":"2015","unstructured":"Luiten JD, Beek MA, Voogd AC, Gobardhan PD, Luiten EJT. Iodine seed- versus wire-guided localization in breast-conserving surgery for non-palpable ductal carcinoma in situ. Br J Surg. 2015;102(13):1665\u20131669. 10.1002\/bjs.9946.","journal-title":"Br J Surg."},{"issue":"1","key":"8744_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1155\/2007\/971816","volume":"29","author":"M Casparie","year":"2007","unstructured":"Casparie M, Tiebosch ATMG, Burger G, et al. Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cell Oncol. 2007;29(1):19\u201324. 10.1155\/2007\/971816.","journal-title":"Cell Oncol."},{"issue":"1","key":"8744_CR20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ejso.2017.11.002","volume":"44","author":"NNY Janssen","year":"2018","unstructured":"Janssen NNY, van la Parra RFD, Loo CE, et al. Breast conserving surgery for extensive DCIS using multiple radioactive seeds. Eur J Surg Oncol. 2018;44(1):67\u201373. 10.1016\/j.ejso.2017.11.002.","journal-title":"Eur J Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-08744-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-020-08744-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-08744-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T19:05:16Z","timestamp":1624388716000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-020-08744-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,23]]},"references-count":20,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["8744"],"URL":"https:\/\/doi.org\/10.1245\/s10434-020-08744-8","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,23]]},"assertion":[{"value":"3 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Marie Colombe Agahozo, A.M. Sofie Berghuis, Esther van den Broek, Linetta B. Koppert, Inge-Marie Obdeijn, and Carolien H.M. van Deurzen declare no potential conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"DISCLOSURE"}}]}}